# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-027849
Filing Date
2025-07-29
Accepted
2025-07-29 16:58:49
Documents
1
Period of Report
2025-03-31
Effectiveness Date
2025-07-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ny20049997x3_ars.pdf | ARS | 2761815
| Complete submission text file | 0001140361-25-027849.txt |  | 3805258

Mailing Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB
Business Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: ARS | Act: 34 | File No.: 001-40782 | Film No.: 251162680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)